Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1561–1584 of 2,006 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Discrete Clear all

Conditions: Acute Promyelocytic Leukemia (APL), Acute Myeloid Leukaemia (AML)
Interventions: Unaided Review First, Then AI-Assisted Review, AI-Assisted Review First, Then Unaided Review; Behavioral
Lead sponsor: Harvard Medical School (HMS and HSDM); Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Multiple Myeloma
Interventions: LGH447, midazolam; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 4
States / cities: Chicago, Illinois • Ann Arbor, Michigan • Rochester, Minnesota + 1 more

Conditions: Breast Cancer
Interventions: sargramostim, therapeutic autologous dendritic cells, trastuzumab, vinorelbine ditartrate; Biological · Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Healthy Volunteers
Interventions: dapsone gel, dapsone gel vehicle, sodium lauryl sulfate, Normal saline; Drug
Lead sponsor: Almirall, S.A.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 237 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Fair Lawn, New Jersey

Conditions: Post-surgical Pain, Total Knee Arthroplasty, Foot/Ankle Surgery, Catheterization for Postop Analgesia
Interventions: ropivacaine 0.2%; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: San Diego, California

Conditions: Eating Disorder, Exposure, Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder, Therapy
Interventions: Imaginal Exposure therapy; Behavioral
Lead sponsor: University of Louisville; Other
Eligibility: 14 Years and older
Enrollment: 208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Hematopoietic/Lymphoid Cancer
Interventions: Paced respiration as part of PEPRR, PEPRR; Device · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 298 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 2
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: HIV Infections
Interventions: VH4524184, Midazolam, Placebo; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy
Interventions: Venoconstrictive Thigh Cuff (VTC); Device
Lead sponsor: National Aeronautics and Space Administration (NASA); Federal
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: HIV
Interventions: Multi-component intervention; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older
Enrollment: 2,794 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 6
States / cities: Birmingham, Alabama • San Diego, California • Miami, Florida + 3 more

Conditions: Major Depression, Sleep
Interventions: TMS; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Advanced Solid Tumor, Advanced Lymphoma
Interventions: AN4005-dose level 0, AN4005-dose level 1, AN4005-dose level 2, AN4005-dose level 3, AN4005-dose level 4, AN4005-food effect; Drug
Lead sponsor: Adlai Nortye Biopharma Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 4
States / cities: Hackensack, New Jersey • The Bronx, New York • Greenville, South Carolina + 1 more

Conditions: Autism
Interventions: Early Start Denver Model (ESDM), Early Intensive Behavioral Intervention (EIBI); Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 12 Months and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Drug; Withdrawal Symptoms, Neonatal, Withdrawal, Fetus and Newborn Affected by Other Maternal Medication
Interventions: BZDs + opiate exposure treated with BPN, Opiates exposure treated with BPN; Drug
Lead sponsor: Gauda, Estelle B., M.D.; Individual
Eligibility: Up to 7 Days
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Anxiety
Interventions: CT, ACT; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Group Meetings
Interventions: TIPSTART; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 34 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Hepatic Cancer, Hepatic Neoplasm, Hepatic Carcinoma
Interventions: 22 gauge needle liver biopsy; Other
Lead sponsor: AdventHealth; Other
Eligibility: 19 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Gestational Diabetes Mellitus
Interventions: BABI-2 Lifestyle Intervention; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Levator Ani Syndrome With Pain and/or Constipation Symptoms.
Interventions: Biofeedback therapy, Botulinum Toxin Type A Injection; Behavioral · Procedure
Lead sponsor: Walter Reed Army Medical Center; Federal
Eligibility: 18 Years and older · Female only
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Anorexia Nervosa, Subthreshold Anorexia Nervosa, Eating Disorder Not Otherwise Specified, Primary Restriction
Interventions: Acceptance and Commitment Therapy, Parent Skills Training; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Prediabetes
Interventions: Hourly 3-Minute Light Walking Breaks, Hourly Stair-Climbing Exercise Snacks; Behavioral
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 69 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Suicidal Ideation
Interventions: Survey; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 100 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Posttraumatic Stress Disorder, Traumatic Brain Injury
Interventions: Reconsolidation of Traumatic Memories (RTM), Prolonged Exposure (PE); Behavioral
Lead sponsor: Uniformed Services University of the Health Sciences; Federal
Eligibility: 18 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Breast Cancer
Interventions: Panitumumab, Nab-paclitaxel, Carboplatin, 5-Fluorouracil, Epirubicin, Cyclophosphamide; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment

A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

Dermal Tolerability of Dapsone Gel in Healthy Volunteers

Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks

Online Imaginal Exposure

Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)

A Study to Investigate Safety, Tolerability, and Pharmacokinetics (PK) of VH4524184 and the Potential for Changes in Cytochrome P450 3A (CYP3A) Activity

Human Research Program Flight Thigh Cuff

HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission

Sleep TMS for Depression

First in Human, Dose Escalation Study of AN4005

Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism

Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study

Comparing Acceptance and Commitment Therapy (ACT) and Cognitive Therapy (CT) for Test Anxiety

Feasibility of Therapy Integrating Peer-sharing, Technology, Aerobic and Resistance Training (TIPSTART)

Endoscopic Ultrasound Guided Liver Biopsy

Balance After Baby Intervention for Women With Recent Gestational Diabetes

Comparison of Biofeedback vs. Botox Injection to Treat Levator Ani Syndrome

Acceptance-Based Separated Family Treatment for Adolescent Anorexia Nervosa

Effects of Hourly Stair-Climbing Exercise Snacks on Metabolic and Vascular Health in Adults With Prediabetes

Improving Our Understanding of Suicidal Ideation in Cancer Survivors

RECONsolidation of Traumatic Memories to ResOLve Post Traumatic Stress Disorder (RECONTROLPTSD)

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer